Anika Therapeutics ANIK Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's goodwill?
- Anika Therapeutics (ANIK) reported goodwill of $7.89M in Q1 2026.
- How has Anika Therapeutics's goodwill changed year-over-year?
- Anika Therapeutics's goodwill increased by 6.3% year-over-year, from $7.42M to $7.89M.
- What is the long-term trend for Anika Therapeutics's goodwill?
- Over 5 years (2020 to 2025), Anika Therapeutics's goodwill has grown at a -0.9% compound annual growth rate (CAGR), from $8.41M to $8.05M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.